RA CAPITAL MANAGEMENT, L.P. sold $4K of VOR (indirect holdings)
RA CAPITAL MANAGEMENT, L.P. sold 213 indirectly-held shares of Vor Biopharma Inc. (VOR) at $19.75 on 2026-07-16.
How this was made
The 30-second read
Why it matters
The only new fact is the reported open-market sale details (date, shares, price, and post-transaction holdings). There is no accompanying narrative about business performance, trials, or guidance.
Market read
Traders may note insider selling, but the disclosed transaction is small and lacks any fundamental catalyst in the text.
What to watch
The filing notes no pre-arranged 10b5-1 plan, but the transaction value is very small, reducing signal-to-noise versus larger or repeated sales.
Background
The article is an SEC Form 4 insider transaction disclosure for Vor Biopharma, reported by RA Capital Management, L.P. as a 10% owner via indirect holdings.
Ticker impact
RA Capital Management, a 10% owner, filed a Form 4 showing an open-market sale of 213 VOR shares at $19.75 on 2026-07-16.
Limited near-term impact; any reaction is likely noise unless follow-on sales or larger transactions appear.
The filing is primary-source (Form 4) but the transaction size ($4,206.75) is small, and there is no accompanying company-specific catalyst or guidance change in the text.
Market effects
None indicated; this is a single-company ownership transaction with no sector-wide signal.
None indicated.
None indicated.
Counterpoint
The sale could be non-informational (taxes, diversification, or routine liquidity) and does not indicate a change in company outlook.
Key entities
- issuerVor Biopharma Inc.
Subject of the Form 4 insider transaction disclosure.
- 10% ownerRA Capital Management, L.P.
Reported the open-market sale of shares in indirect holdings.
